Clinical trial
Intravenous Allopurinol in Heart Failure
NCT00181155 · Johns Hopkins University, Other · Completed
Key facts
| NCT number | NCT00181155 |
|---|---|
| Title | Intravenous Allopurinol in Heart Failure |
| Official title | Effects of Xanthine Oxidase Inhibition on Mechano-Energetic Coupling in Heart Failure |
| Lead sponsor | Johns Hopkins University, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Congestive Heart Failure |
| Intervention type | Drug |
| Interventions | Allopurinol, Placebo |
| Enrollment | 18 |
| Start date | Nov 1, 2004 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Sep 16, 2005 |
| Last update posted | May 30, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: